11 – 20 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article
-
Mark
Patient registries for home oxygen research and evaluation
(
- Contribution to journal › Article
- 2018
-
Mark
The Efficiency Index (EFFi), based on volumetric capnography, may allow for simple diagnosis and grading of COPD
(
- Contribution to journal › Article
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients
(
- Contribution to journal › Article
-
Mark
Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS pilot study
(
- Contribution to journal › Article
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
Authors’ reply
(
- Contribution to journal › Letter
-
Mark
Burn injury during long-term oxygen therapy in Denmark and Sweden : The potential role of smoking
(
- Contribution to journal › Article